294 related articles for article (PubMed ID: 20835245)
1. Alternative expression analysis by RNA sequencing.
Griffith M; Griffith OL; Mwenifumbo J; Goya R; Morrissy AS; Morin RD; Corbett R; Tang MJ; Hou YC; Pugh TJ; Robertson G; Chittaranjan S; Ally A; Asano JK; Chan SY; Li HI; McDonald H; Teague K; Zhao Y; Zeng T; Delaney A; Hirst M; Morin GB; Jones SJ; Tai IT; Marra MA
Nat Methods; 2010 Oct; 7(10):843-7. PubMed ID: 20835245
[TBL] [Abstract][Full Text] [Related]
2. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
[TBL] [Abstract][Full Text] [Related]
3. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays.
Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Danenberg PV; Shimada H
Int J Oncol; 2005 Aug; 27(2):371-6. PubMed ID: 16010417
[TBL] [Abstract][Full Text] [Related]
4. Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer.
Griffith M; Mwenifumbo JC; Cheung PY; Paul JE; Pugh TJ; Tang MJ; Chittaranjan S; Morin RD; Asano JK; Ally AA; Miao L; Lee A; Chan SY; Taylor G; Severson T; Hou YC; Griffith OL; Cheng GS; Novik K; Moore R; Luk M; Owen D; Brown CJ; Morin GB; Gill S; Tai IT; Marra MA
Pharmacogenomics J; 2013 Apr; 13(2):148-58. PubMed ID: 22249354
[TBL] [Abstract][Full Text] [Related]
5. Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments.
Richard H; Schulz MH; Sultan M; Nürnberger A; Schrinner S; Balzereit D; Dagand E; Rasche A; Lehrach H; Vingron M; Haas SA; Yaspo ML
Nucleic Acids Res; 2010 Jun; 38(10):e112. PubMed ID: 20150413
[TBL] [Abstract][Full Text] [Related]
6. Quantitative visualization of alternative exon expression from RNA-seq data.
Katz Y; Wang ET; Silterra J; Schwartz S; Wong B; Thorvaldsdóttir H; Robinson JT; Mesirov JP; Airoldi EM; Burge CB
Bioinformatics; 2015 Jul; 31(14):2400-2. PubMed ID: 25617416
[TBL] [Abstract][Full Text] [Related]
7. The colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information.
Allen WL; Jithesh PV; Oliver GR; Proutski I; Longley DB; Lenz HJ; Proutski V; Harkin P; Johnston PG
BMC Cancer; 2010 Dec; 10():687. PubMed ID: 21172019
[TBL] [Abstract][Full Text] [Related]
8. Design of RNA splicing analysis null models for post hoc filtering of Drosophila head RNA-Seq data with the splicing analysis kit (Spanki).
Sturgill D; Malone JH; Sun X; Smith HE; Rabinow L; Samson ML; Oliver B
BMC Bioinformatics; 2013 Nov; 14():320. PubMed ID: 24209455
[TBL] [Abstract][Full Text] [Related]
9. [Identification of nine novel alternative splicing isoforms of RHD mRNA].
Xu XG; Wu JJ; Hong XZ; Zhu FM; Yan LX
Yi Chuan; 2006 Oct; 28(10):1213-8. PubMed ID: 17035176
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
11. FIRMA: a method for detection of alternative splicing from exon array data.
Purdom E; Simpson KM; Robinson MD; Conboy JG; Lapuk AV; Speed TP
Bioinformatics; 2008 Aug; 24(15):1707-14. PubMed ID: 18573797
[TBL] [Abstract][Full Text] [Related]
12. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
13. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome.
Sultan M; Schulz MH; Richard H; Magen A; Klingenhoff A; Scherf M; Seifert M; Borodina T; Soldatov A; Parkhomchuk D; Schmidt D; O'Keeffe S; Haas S; Vingron M; Lehrach H; Yaspo ML
Science; 2008 Aug; 321(5891):956-60. PubMed ID: 18599741
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases.
Chen Q; Xia HW; Ge XJ; Zhang YC; Tang QL; Bi F
Asian Pac J Cancer Prev; 2013; 14(12):7421-6. PubMed ID: 24460313
[TBL] [Abstract][Full Text] [Related]
15. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples.
Nacu S; Yuan W; Kan Z; Bhatt D; Rivers CS; Stinson J; Peters BA; Modrusan Z; Jung K; Seshagiri S; Wu TD
BMC Med Genomics; 2011 Jan; 4():11. PubMed ID: 21261984
[TBL] [Abstract][Full Text] [Related]
16. Identifying differential alternative splicing events from RNA sequencing data using RNASeq-MATS.
Park JW; Tokheim C; Shen S; Xing Y
Methods Mol Biol; 2013; 1038():171-9. PubMed ID: 23872975
[TBL] [Abstract][Full Text] [Related]
17. A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology.
Mehta S; Tsai P; Lasham A; Campbell H; Reddel R; Braithwaite A; Print C
Cancer Res; 2016 Dec; 76(24):7151-7159. PubMed ID: 27913434
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
Amankwatia EB; Chakravarty P; Carey FA; Weidlich S; Steele RJ; Munro AJ; Wolf CR; Smith G
Br J Cancer; 2015 Apr; 112(9):1480-90. PubMed ID: 25919696
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis.
Thorsen K; Schepeler T; Øster B; Rasmussen MH; Vang S; Wang K; Hansen KQ; Lamy P; Pedersen JS; Eller A; Mansilla F; Laurila K; Wiuf C; Laurberg S; Dyrskjøt L; Ørntoft TF; Andersen CL
BMC Genomics; 2011 Oct; 12():505. PubMed ID: 21999571
[TBL] [Abstract][Full Text] [Related]
20. Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing.
Castle J; Garrett-Engele P; Armour CD; Duenwald SJ; Loerch PM; Meyer MR; Schadt EE; Stoughton R; Parrish ML; Shoemaker DD; Johnson JM
Genome Biol; 2003; 4(10):R66. PubMed ID: 14519201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
